Press Releases
Search
-
30 Aug 2017
bioMérieux – First-Half 2017 Results
Solid sales dynamic, with sales up 11.3% over the first half at constant exchange rates and scope of consolidation: €1,134 million in sales Up 13.3% as reported 30-bp improvement in contributive opera...
-
31 Jul 2017
bioMérieux receives FDA clearance for expanded pathogen identification capability on VITEK® MS
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that VITEK® MS, its MALDI-TOF1 Mass Spectrometry System for rapid pathogen identification, has received 510(k) clearanc...
-
27 Jul 2017
Sysmex and bioMérieux Agreed to Dissolve the Joint Venture Sysmex bioMérieux Co., Ltd.
Sysmex Corporation (“Sysmex”) and bioMérieux S.A. (“bioMérieux”) (Paris:BIM) announce they have agreed to transfer all of Sysmex’ holdings in Sysmex bioMérieux Co., Ltd. (Tokyo, Japan) to bioMérieux t...
-
20 Jul 2017
Information financière du 2e trimestre 2017
Good sales dynamic confirmed in second-quarter 2017, with sales up 11.3% over the first half at constant exchange rates and scope of consolidation: €1,134 million in sales Up 13.3% as reported Noticea...
-
01 Jun 2017
boMérieux receives FDA Clearance for BioFire's FilmArray® Respiratory Panel 2 (RP2)
The FilmArray® RP2 reduces sample-to-result time to only 45 minutes while enhancing pathogen coverage and overall sensitivity...
-
20 Apr 2017
The FilmArray® Respiratory Panel 2 plus (RP2plus) gets CE marked
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the FilmArray® Respiratory Panel 2 plus (RP2plus) is CE marked. The FilmArray® RP2plus panel tests for 22 pathogen...